Okyo Pharma (OKYO)

Last close As at 27/10/2025

USD2.65

0.26 (10.88%)

Market capitalisation

USD100m

Okyo Pharma is a clinical-stage biopharmaceutical company developing therapeutic compounds to treat ocular indications including dry eye disease and neuropathic corneal pain.

Latest Insights

Healthcare | Non client QV

Okyo Pharma — Targeting underserved corneal diseases

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Gary Jacob, PhD

    CEO

  • Keeren Shah

    CFO

Thematics